Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 6, 1997 - Issue 12
Submit an article Journal homepage
35
Views
14
CrossRef citations to date
0
Altmetric
Review

Neuropeptide Y receptor antagonists in obesity

Donald R Gehlert Mail Code 0510, Lilly Neuroscience,Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA. [email protected]
&
Philip A Hipskind Mail Code 0510, Lilly Neuroscience,Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA. [email protected]
Pages 1827-1838 | Published online: 23 Feb 2005

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Sébastien Guery, Yveline Rival & Camille G. Wermuth. (2002) EFFICIENT SYNTHESIS OF A SELECTIVE Y5 RECEPTOR ANTAGONIST. Synthetic Communications 32:11, pages 1715-1719.
Read now

Articles from other publishers (13)

Larry Yet. 2018. Privileged Structures in Drug Discovery. Privileged Structures in Drug Discovery 284 320 .
Larry Yet. 2018. Privileged Structures in Drug Discovery. Privileged Structures in Drug Discovery 194 236 .
Larry Yet. 2018. Privileged Structures in Drug Discovery. Privileged Structures in Drug Discovery 59 82 .
Sumit Deswal & Nilanjan Roy. (2007) A novel range based QSAR study of human neuropeptide Y (NPY) Y5 receptor inhibitors. European Journal of Medicinal Chemistry 42:4, pages 463-470.
Crossref
Valeria P. Carlini, Helgi B. Schiöth & Susana R. de Barioglio. (2006) Melanin-concentrating hormone (MCH) reverts the behavioral effects induced by inescapable stress. Peptides 27:9, pages 2300-2306.
Crossref
S. Deswal & N. Roy. (2006) Quantitative structure activity relationship of benzoxazinone derivatives as neuropeptide Y Y5 receptor antagonists. European Journal of Medicinal Chemistry 41:4, pages 552-557.
Crossref
Sung-Eun Kwak, Ji-Eun Kim, Duk-Soo Kim, Moo-Ho Won, Hui-Chul Choi, Yeong-In Kim, Hong-Ki Song, Soo-Young Choi & Tae-Cheon Kang. (2005) Differential effects of vigabatrin and zonisamide on the neuropeptide Y system in the hippocampus of seizure prone gerbil. Neuropeptides 39:5, pages 507-513.
Crossref
Graham S Poindexter, Marc A Bruce, J.Guy Breitenbucher, Mendi A Higgins, S.-Y Sit, Jeffrey L Romine, Scott W Martin, Sally A Ward, Rachel T McGovern, Wendy Clarke, John Russell & Ildiko Antal-Zimanyi. (2004) Dihydropyridine neuropeptide Y Y 1 receptor antagonists 2. Bioorganic & Medicinal Chemistry 12:2, pages 507-521.
Crossref
Graham S. Poindexter, Marc A. Bruce, Karen L. LeBoulluec, Ivo Monkovic, Scott W. Martin, Eric M. Parker, Larry G. Iben, Rachel T. McGovern, Astrid A. Ortiz, Jennifer A. Stanley, Gail K. Mattson, Michael Kozlowski, Meredith Arcuri & Ildiko Antal-Zimanyi. (2002) Dihydropyridine Neuropeptide Y Y1 Receptor Antagonists. Bioorganic & Medicinal Chemistry Letters 12:3, pages 379-382.
Crossref
Ildik� Antal Zim�nyi & Graham S. Poindexter. (2000) NPY-Ergic agents for the treatment of obesity. Drug Development Research 51:2, pages 94-111.
Crossref
Miles G. Siegel, Michael O. Chaney, Robert F. Bruns, Michael P. Clay, Douglas A. Schober, Anne M. Van Abbema, Douglas W. Johnson, Buddy E. Cantrell, Patric J. Hahn, David C. Hunden, Donald R. Gehlert, Hamideh Zarrinmayeh, Paul L. Ornstein, Dennis M. Zimmerman & Gary A. Koppel. (1999) Rapid parallel synthesis applied to the optimization of a series of potent nonpeptide neuropeptide Y-1 receptor antagonists. Tetrahedron 55:39, pages 11619-11639.
Crossref
Yasushi Murakami, Sanji Hagishita, Tetsuo Okada, Makoto Kii, Hiroshi Hashizume, Tatsuroh Yagami & Masafumi Fujimoto. (1999) 1,3-Disubstituted benzazepines as neuropeptide Y Y1 receptor antagonists. Bioorganic & Medicinal Chemistry 7:8, pages 1703-1714.
Crossref
Yasushi Murakami, Hirokazu Hara, Tetsuo Okada, Hiroshi Hashizume, Makoto Kii, Yasunobu Ishihara, Michio Ishikawa, Mayumi Shimamura, Shin-inchi Mihara, Goro Kato, Kohji Hanasaki, Sanji Hagishita & Masafumi Fujimoto. (1999) 1,3-Disubstituted Benzazepines as Novel, Potent, Selective Neuropeptide Y Y1 Receptor Antagonists. Journal of Medicinal Chemistry 42:14, pages 2621-2632.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.